Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$24.32 - $75.3 $162,944 - $504,510
-6,700 Reduced 0.33%
2,012,250 $151 Million
Q1 2022

May 16, 2022

SELL
$24.73 - $51.25 $2.16 Million - $4.48 Million
-87,500 Reduced 4.15%
2,018,950 $54.2 Million
Q4 2021

Feb 14, 2022

SELL
$35.48 - $67.33 $9.04 Million - $17.2 Million
-254,877 Reduced 10.79%
2,106,450 $100 Million
Q1 2021

May 17, 2021

SELL
$88.19 - $140.01 $33.9 Million - $53.8 Million
-384,000 Reduced 13.99%
2,361,327 $223 Million
Q3 2019

Nov 14, 2019

BUY
$36.9 - $57.76 $6.56 Million - $10.3 Million
177,777 Added 6.92%
2,745,327 $103 Million
Q2 2019

Aug 14, 2019

BUY
$26.67 - $43.63 $68.5 Million - $112 Million
2,567,550 New
2,567,550 $104 Million

About Turning Point Therapeutics, Inc.


  • Ticker TPTX
  • Exchange NASDAQ
  • Shares Outstandng 50,074,300
More about TPTX
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.